VECTORS Study: Are We Going in the Right Direction?
SUMMARY AND COMMENT
October 27, 2009
Joel Stein, MD
Contrary to expectation, high-intensity constraint-induced therapy produced worse outcomes than lower-intensity constraint-induced therapy or conventional therapy when used early after stroke.
Reviewing:
Dromerick AW et al., Neurology 2009 Jul 21; 73:195
Cramer SC., Neurology 2009 Jul 21; 73:170
Neurological Comorbidity and Epilepsy Treatment
SUMMARY AND COMMENT
October 20, 2009
Andrew J. Cole, MD, FRCP(C)
A review highlights the dearth of class 1 evidence regarding optimal epilepsy treatment and drug–drug interactions in the setting of comorbid disease.
Reviewing:
Zaccara G., Acta Neurol Scand 2009 Jul; 120:1
Link Found Between Sleep Loss and Colitis
SUMMARY AND COMMENT
October 20, 2009
Jeffrey M. Ellenbogen, MMSc, MD
In mice, sleep deprivation worsens colonic inflammation.
Reviewing:
Tang Y et al., Sleep Med 2009 Jun; 10:597
FOUR Score Coma Scale in Medical Intensive Care
SUMMARY AND COMMENT
October 20, 2009
David M. Greer, MD, MA
This relatively new coma assessment scale performed well in predicting outcome in medical intensive care, but it needs further validation.
Reviewing:
Iyer VN et al., Mayo Clin Proc 2009 Aug; 84:694
Patent Foramen Ovale and Risk for Stroke Recurrence
SUMMARY AND COMMENT
October 13, 2009
Julien Bogousslavsky, MD
A meta-analysis finds a low risk but does not provide a definitive answer on whether PFO closure can reduce the risk in selected patients.
Reviewing:
Almekhlafi MA et al., Neurology 2009 Jul 14; 73:89
Review of Associations Between Sleepiness and Depression
SUMMARY AND COMMENT
October 13, 2009
Quentin Regestein, MD
Sleep and depression are so complex that a review article can only describe, not answer, specific questions about their interaction.
Reviewing:
Chellappa SL et al., Sleep Med 2009 May; 10:505
Neuroimaging with Pittsburgh Compound B in Patients with Mild Cognitive Impairment
SUMMARY AND COMMENT
October 13, 2009
Rawan Tarawneh, MD, and John C. Morris, MD
MCI patients with amyloid retention identified by PiB most likely have very early AD.
Reviewing:
Wolk DA et al., Ann Neurol 2009 May; 65:557
Effect of Statins on Responses to Interferon Beta-1a
SUMMARY AND COMMENT
October 6, 2009
Hillel Panitch, MD
A retrospective study suggests that statins do not interfere with the therapeutic effects of IFNβ-1a in multiple sclerosis, but methodologic problems render the issue unresolved.
Reviewing:
Rudick RA et al., Neurology 2009 Jun 9; 72:1989
Expanding the Window for Acute Stroke Treatment
SUMMARY AND COMMENT
October 6, 2009
James S. McKinney, MD
New recommendations from the American Heart Association/American Stroke Association on using t-PA between 3 and 4.5 hours after stroke onset
Reviewing:
del Zoppo GJ et al., Stroke 2009 Aug; 40:2945
Maintaining Mental Fitness in Old Age
SUMMARY AND COMMENT
September 29, 2009
Kirk R. Daffner, MD
What factors affect maintenance of cognitive function or contribute to cognitive decline?
Reviewing:
Yaffe K et al., Neurology 2009 Jun 9; 72:2029